XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.3
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
 6 Months Ended
Sep. 30, 2024
Accounts Payable And Accrued Liabilities  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

NOTE 7.  ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

At September 30, 2024 and March 31, 2024, accounts payable and accrued liabilities were comprised of the following (in thousands):

 

          
   September 30, 2024
(Unaudited)		  March 31, 2024
Accounts payable and amounts accrued to CRO  $49   $1,413 
Accrued bonuses and other payroll-related expenses   371    525 
Accrued accounting and auditing fees   127    189 
Accrued legal fees   54    194 
Accrued other professional fees   33    157 
Other accounts payable   172    136 
Accrued clinical and R&D services   3    179 
Other   36    43 
Total accounts payable and accrued liabilities  $845   $2,836 

 

The decrease in accounts payable and accrued liabilities from $2.8 million as of March 31, 2024 to $0.8 million as of September 30, 2024 is primarily attributable to the write-off of $1.486 million in connection with the settlement with Parexel. Refer to the “iOx – Parexel Master Services Agreement” section of Note 12, “Commitments and Contingent Liabilities” for further discussion regarding this matter.